Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study

Cisplatin plus 5‐fluorouracil is regarded as standard neoadjuvant chemotherapy for esophageal squamous cell carcinoma (ESCC) in Japan, but the prognosis remains poor. We have previously described how definitive chemoradiotherapy with docetaxel, nedaplatin, and 5‐fluorouracil (DNF) led to a very high...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Ohnuma, Hiroyuki, Sato, Yasushi, Hayasaka, Naotaka, Matsuno, Teppei, Fujita, Chisa, Sato, Masanori, Osuga, Takahiro, Hirakawa, Masahiro, Miyanishi, Koji, Sagawa, Tamotsu, Fujikawa, Koshi, Ohi, Motoh, Okagawa, Yutaka, Tsuji, Yasushi, Hirayama, Michiaki, Ito, Tatsuya, Nobuoka, Takayuki, Takemasa, Ichiro, Kobune, Masayoshi, Kato, Junji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215867/
https://ncbi.nlm.nih.gov/pubmed/30137686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13772
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados